Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema

Table 3

Characteristics of eyes with residual subretinal fluid after Ranibizumab.

Number	Age	HbA1c	CMT at baseline	CMT at 3 months	DR severity	PRP status	eGFR	Serum albumin
1	62	6.3	475	361	PDR	≤6 months	59.6	3.4
2	58	6.1	392	284	PDR	>6 months	49.2	4.3
3	44	5.4	380	258	PDR	Naïve	50.4	3.2
4	61	4.8	500	414	PDR	Naïve	10.5	1.9
5	62	6.6	690	440	PDR	≤6 months	59.9	N/A

CMT: central macular thickness; DR: diabetic retinopathy, designated as proliferative or nonproliferative diabetic retinopathy; eGFR: estimated glomerular filtration rate; PDR: proliferative diabetic retinopathy; PRP: panretinal photocoagulation.